A model of the economic impact of a bipolar disorder screening program in primary care
- PMID: 19689919
- DOI: 10.4088/JCP.08m04939
A model of the economic impact of a bipolar disorder screening program in primary care
Abstract
Objective: Unrecognized bipolar disorder in patients presenting with a major depressive episode may lead to delayed diagnosis, inappropriate treatment, and excessive costs. This study models the cost effectiveness of screening for bipolar disorder among adults presenting for the first time with symptoms of major depressive disorder.
Method: A decision-analysis model was used to evaluate the outcomes and cost over 5 years of screening versus not screening for bipolar disorder. Screening was defined as a 1-time administration of the Mood Disorder Questionnaire at the initial visit followed by referral to a psychiatrist for patients screening positive for bipolar disorder. Health states included correctly diagnosed bipolar disorder, unrecognized bipolar disorder, and correctly diagnosed major depressive episodes. Model outcomes included rates of correct diagnosis of bipolar disorder and discounted costs (2006 US dollars) of screening and treating major depressive episodes. Literature was the primary source of data and was collected from September 2007 through March 2009.
Results: According to the model, 1,000 adults in a health plan with 1 million adult members annually present with symptoms of major depressive disorder. An additional 38 patients were correctly diagnosed with depression (unipolar or a major depressive episode) or bipolar disorder (440 with screening vs 402 without screening) through a 1-time screening for bipolar disorder. Estimated 5-year discounted costs per patient were $36,044 without screening and $34,107 with screening (savings of $1,937). Accordingly, total 5-year budgetary savings were estimated at $1.94 million. Results were most sensitive to difference in treatment costs for patients with recognized versus unrecognized bipolar disorder.
Conclusion: A 1-time screening program for bipolar disorder, when patients first present with a major depressive episode, can reduce health care costs to managed-care plans.
Copyright 2009 Physicians Postgraduate Press, Inc.
Similar articles
-
The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.J Affect Disord. 2007 Jan;97(1-3):171-9. doi: 10.1016/j.jad.2006.06.018. Epub 2006 Jul 24. J Affect Disord. 2007. PMID: 16860396
-
Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode.J Affect Disord. 2009 Apr;114(1-3):299-304. doi: 10.1016/j.jad.2008.06.025. Epub 2008 Aug 13. J Affect Disord. 2009. PMID: 18701169
-
Costs associated with attempted suicide among individuals with bipolar disorder.J Ment Health Policy Econ. 2010 Jun;13(2):87-92. J Ment Health Policy Econ. 2010. PMID: 20919595
-
Clinical and economic effects of unrecognized or inadequately treated bipolar disorder.J Psychiatr Pract. 2008 May;14 Suppl 2:31-8. doi: 10.1097/01.pra.0000320124.91799.2a. J Psychiatr Pract. 2008. PMID: 18677197 Review.
-
[Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].Encephale. 2003 May-Jun;29(3 Pt 1):248-53. Encephale. 2003. PMID: 12876549 Review. French.
Cited by
-
A Magnetic Resonance Spectroscopy Study on Polarity Subphenotypes in Bipolar Disorder.Diagnostics (Basel). 2024 May 31;14(11):1170. doi: 10.3390/diagnostics14111170. Diagnostics (Basel). 2024. PMID: 38893696 Free PMC article.
-
Examination of the predictive value of structural magnetic resonance scans in bipolar disorder: a pattern classification approach.Psychol Med. 2014 Feb;44(3):519-32. doi: 10.1017/S0033291713001013. Epub 2013 Jun 5. Psychol Med. 2014. PMID: 23734914 Free PMC article.
-
Using decision-analysis modelling to estimate the economic impact of the identification of unrecognised bipolar disorder in primary care: the untapped potential of screening.Int J Bipolar Disord. 2022 Jun 10;10(1):15. doi: 10.1186/s40345-022-00261-9. Int J Bipolar Disord. 2022. PMID: 35680705 Free PMC article.
-
Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.Am Health Drug Benefits. 2014 Dec;7(9):489-99. Am Health Drug Benefits. 2014. PMID: 25610528 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical